[Inflammasome and gout]
- PMID: 27418053
- DOI: 10.1007/s00393-016-0131-1
[Inflammasome and gout]
Similar articles
-
Canakinumab for gout: a specific, patient-profiled indication.Expert Rev Clin Immunol. 2014 Mar;10(3):339-47. doi: 10.1586/1744666X.2014.880653. Epub 2014 Jan 22. Expert Rev Clin Immunol. 2014. PMID: 24451032 Review.
-
Interleukin-1 as a therapeutic target in gout.Curr Opin Rheumatol. 2015 Mar;27(2):156-63. doi: 10.1097/BOR.0000000000000143. Curr Opin Rheumatol. 2015. PMID: 25633244 Review.
-
Hyperuricemia and gout: new insights into pathogenesis and treatment.Bull NYU Hosp Jt Dis. 2007;65(3):215-21. Bull NYU Hosp Jt Dis. 2007. PMID: 17922673 Review.
-
Gout, tophi and the wonders of NETs.Arthritis Res Ther. 2014;16(5):431. doi: 10.1186/s13075-014-0431-2. Arthritis Res Ther. 2014. PMID: 25606589 Free PMC article. No abstract available.
-
[Crystal-induced activation of the inflammasome: gout and pseudogout].Z Rheumatol. 2009 Nov;68(9):733-9. doi: 10.1007/s00393-009-0489-4. Z Rheumatol. 2009. PMID: 19838718 German.
Cited by
-
[Immunology of systemic inflammatory diseases].Orthopade. 2018 Nov;47(11):891-898. doi: 10.1007/s00132-018-3647-z. Orthopade. 2018. PMID: 30267123 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical